This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Earle E Bain: Innovator in ADHD Treatment
Introduction
Earle E Bain is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of pharmacology, particularly in the treatment of attention-deficit/hyperactivity disorder (ADHD). His innovative work has led to the development of compounds that target nicotinic receptors, providing new avenues for managing ADHD symptoms.
Latest Patents
Earle E Bain holds 1 patent for his invention titled "Treatment of attention-deficit/hyperactivity disorder - 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof." This patent describes effective nicotinic receptor agonist compounds that have demonstrated pharmacological effects for symptoms associated with ADHD.
Career Highlights
Earle E Bain is associated with Abbott Laboratories Corporation, a leading global healthcare company. His work at Abbott has allowed him to focus on innovative treatments that improve the quality of life for individuals with ADHD.
Collaborations
Throughout his career, Earle has collaborated with esteemed colleagues such as Walid M Abi-Saab and Sandeep Dutta. These collaborations have fostered a productive environment for research and development in the field of ADHD treatment.
Conclusion
Earle E Bain's contributions to ADHD treatment through his patented innovations highlight his role as a significant figure in pharmacology. His work continues to influence the development of effective therapies for managing ADHD symptoms.